about
Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabul...
Read More
2.77
0.44
(18.88%)
1.6M
XNAS Volume
High volume+gain today
XNAS 10 Aug, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Veru Inc is on 12 Aug 2026 for the purpose of Veru Inc Third Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Neutral
Veru Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..